Medicines for cardiovascular health: are they used appropriately?

$27.00

Phone, fax or email orders:

CanPrint
Tel. 1300 889 873
Fax 02 6293 8333
Email

Read the related media release.

View other publications in the same series: Cardiovascular disease series.

View other publications by the same authors: Senes S & Penm E.

View other publications in the same subject area: Cardiovascular disease.

Cardiovascular disease series no. 27

Medicines for cardiovascular health: are they used appropriately? covers trends in prescription and supply of these medicines, patterns of supply by geographic area and patient socioeconomic level, whether patients take medicines as intended, adverse events associated with these medicines, initiatives to improve the quality of use of medicines, and government expenditure on cardiovascular medicines. This report will be of interest to policy makers, health professionals and researchers in the field, as well as to the broader community.

Authored by Senes S & Penm E.

Published 23 May 2007; ISSN 1323 9236; ISBN-13 978 1 74024 689 7; AIHW cat. no. CVD 36; 92pp.; $27.00


View online for free

On this page:


Full publication (461K PDF)

  • Preliminary material (169K PDF)
    • Title and verso pages
    • Contents
    • Acknowledgements
    • Key points
  • Sections
    • Introduction (169K PDF)
    • Background (169K PDF)
      • Quality use of medicines
      • Opportunities and challenges for quality use of medicines
      • Medicines and cardiovascular disease
    • Use of cardiovascular medicines for any health condition (169K PDF)
      • Supply of cardiovascular medicines in the community
      • Cardiovascular medicines prescribed in general practice
    • Use of medicines for cardiovascular disease (169K PDF)
    • Quality use of cardiovascular medicines (169K PDF)
      • Medicines prescribed for cardiovascular disease
      • Concordance with medicines
      • National Prescribing Service initiatives
      • National Institute of Clinical Studies initiatives
      • National Primary Care Collaboratives
      • Section 100 initiative
      • Drug-adverse events
    • Expenditure on cardiovascular medicines(169K PDF)
    • Discussion (169K PDF)
  • End matter (234K PDF)
    • Appendixes
      • Appendix tables
      • Appendix figures
      • The Anatomical Therapeutic Chemical (ATC) classification system
      • Data sources
      • Methods
      • National bodies with responsibility for quality use of medicines
    • Glossary
    • References
    • List of tables
    • List of figures

Additional material

Appendix tables

  1. Table E1: Medicines prescribed or supplied in hypertension
  2. Table E2: Medicines prescribed or supplied in lipid disorders
  3. Table E3: Medicines prescribed or supplied in diabetes
  4. Table E4: Medicines prescribed or supplied in ischaemic heart disease
  5. Table E5: Medicines prescribed or supplied in heart failure
  6. Table E6: Medicines prescribed or supplied in arrhythmias
  7. Table E7: Medicines prescribed or supplied in stroke
  8. Table E8: Medicines prescribed or supplied in peripheral vascular disease